Recent and select publications

De Silva RA, Jain S, Lears KA, Chong HS, Kang CS, Sun X, Rogers BE:  Copper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical development.  Nucl Med Biol 39:1099-1104, 2012.  PMCID: PMC3470735.

Kang CS, Wu N, Chen Y, Bandara N, Liu D, Lewis MR, Rogers BE, Chong HS:   Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for   PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation. J Inorg Biochem 154:60-66, 2016. PMCID: PMC4679499.

Kapoor V, Dadey DY, Nguyen K, Wildman SA, Hoye K, Khudanyan A, Bandara N, Rogers BE, Thotala D, Hallahan DE: Tumor specific binding of radiolabeled PEGylated GIRLRG peptide; a novel agent for targeting cancers. J Nucl Med Epub, 2016.

Lears KA, Ferdani R, Liang K, Zheleznyak A, Andrews R, Sherman CD, Achilefu S, Anderson CJ, Rogers BE:  In vitro and in vivo evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor-Expressing Prostate Cancer.  J Nucl Med 52:470-477, 2011.  PMCID: PMC3088991.

Lears KA, Parry JJ, Andrews R, Nguyen K, Wadas TJ, Rogers BE: Adenoviral-mediated imaging of gene transfer using a somatostatin receptor-cytosine deaminase fusion protein. Cancer Gene Ther 22:215-221, 2015. PMCID: PMC4409539.

Liu L, Rogers BE, Aladyshkina N, Cheng B, Lokitz SJ, Curiel DT, Mathis JM: Construction and radiolabeling of adenovirus variants that incorporate human metallothionein into protein IX for analysis of biodistribution. Mol Imaging 13:1-12, 2014. PMCID: None.

Richter S, Wuest M, Bergman CN, Way JD, Krieger S, Rogers BE, Wuest F: Rerouting the metabolic pathway of 18F-labeled peptides: the influence of prosthetic groups. Bioconjug Chem 26:201-212, 2015. PMCID: None.

Richter S, Wuest M, Bergman CN, Krieger S, Rogers BE, Wuest F: Metabolically stabilized 68Ga-NOTA-Bombesin for PET imaging of prostate cancer and influence of protease inhibitor phosphoramidon.  Mol Pharm 13:1347-1357, 2016. PMCID: None.

Rogers BE, Bigott HM, McCarthy DW, Della Manna D, Kim J, Sharp TL, Welch MJ:  MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.  Bioconjug Chem 14:756-763, 2003. PMCID: None.

Rogers BE, Roberson PL, Shen S, Khazaeli MB, Carpenter M, Yokoyama S, Brechbiel MW, LoBuglio AF, Buchsbaum DJ:  Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.  Cancer Biother Radiopharm 20:502-513, 2005. PMCID: None.

Sin, I.; Kang, C.; Bandara, N.; Sun, X; Zhong, Y.; Rogers, B. E; Chong, H.S., “Novel Hexadentate and Pentadentate Chelators for 64Cu-based Targeted PET Imaging”, Med. Chem. 2014, 22, 2553-2562.